NEW YORK, Feb. 3, 2017 /PRNewswire/ --

Dr. Reddy's Laboratories Limited (RDY)

Lifshitz & Miller announces investigation on behalf of RDY investors concerning the warning letter RDY received from the FDA regarding three of RDY's manufacturing facilities.

If you are an RDY investor, and seek information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Exterran Corporation (EXTN)

Lifshitz & Miller announces investigation on behalf of EXTN investors concerning EXTN restating its financial statements for 2015 in connection with irregularities in accounting.

If you are a EXTN investor, and seek additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Gigamon Inc. (GIMO)

Lifshitz & Miller announces investigation on behalf of GIMO investors concerning reduced product bookings in GIMO's North America West region.

If you are a GIMO investor, and seek additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

KemPharm, Inc. (KMPH)

Lifshitz & Miller announces investigation on behalf of KMPH investors concerning KMPH's "abuse-deterrent" labeling for Apadaz.

If you are a KMPH investor, and seek additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Navient Corporation (NAVI)

Lifshitz & Miller announces investigation on behalf of NAVI investors concerning NAVI's loan servicing practices.

If you are a NAVI investor, and seek additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

NCI, Inc. (NCIT)

Lifshitz & Miller announces investigation on behalf of NCIT investors concerning an internal investigation revealing that NCIT's controller embezzled approximately $18 million from NCIT.

If you are an NCIT investor, and seek additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Opus Bank (OPB)

Lifshitz & Miller announces investigation on behalf of OPB investors concerning OPB's representations regarding its loan quality.

If you are an OPB investor, and seek additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

PixarBio Corporation (PXRB)

Lifshitz & Miller announces investigation on behalf of PXRB investors concerning PixarBio assertions concerning its business combinations and current shareholders and PXRB's current and prospective development efforts.

If you are a PXRB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Yahoo! Inc. (YHOO)

Lifshitz & Miller announces investigation on behalf of YHOO investors concerning the theft of more than 500 million user accounts in late 2014.

If you are a YHOO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-dr-reddys-laboratories-limited-exterran-corporation-gigamon-inc-kempharm-inc-navient-corporation-nci-inc-opus-bank-pixarbio-corporation-and-yahoo-inc-300402083.html

SOURCE Lifshitz & Miller Law Firm